CHYM vs CXM Stock Comparison
CHYM currently leads CXM in this stock comparison, with AIQ scores of 67 vs 66. The clearest difference is momentum, while CXM has the stronger value profile.
What is the main difference between CHYM and CXM?
CHYM leads the current stock comparison as Chime Financial, Inc. Class A Common Stock, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Chime Financial, Inc. Class A Common Stock vs Sprinklr, Inc.
CHYM leads
CHYM leads by 1 AIQ points, primarily on Momentum and Quality.
Fragile: 3 of 6 evidence groups support CHYM, and its current signal state is conflicted.
Chime Financial, Inc. Class A Common Stock
Sprinklr, Inc.
The Algovestiq AIQ Score currently favors CHYM over CXM, 67 versus 66 as of Nov 15, 2026. CHYM's advantage is driven primarily by stronger momentum and quality, while CXM holds the stronger value profile. CHYM also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor CHYM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. CHYM lead: Stable — the AIQ differential has held near 1 points over 30 sessions.
Compare Chime Financial, Inc. Class A Common Stock and Sprinklr, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare CHYM and CXM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value40 vs 63CXM +23
- Momentum83 vs 71CHYM +12
- Quality74 vs 64CHYM +10
- Risk Resilience52 vs 62CXM +10
3 of 6 evidence groups favor CHYM. CHYM’s edge is concentrated in momentum and quality; CXM keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +3
New signals
- Accumulation Pattern — bullish, volume, medium horizon (1.56x)
- RSI Overbought — bearish, momentum, short horizon
- Stochastic Overbought Rollover — bearish, momentum, short horizon
Largest factor move: Value -1, not enough on its own to move the overall score.
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.62x)
CHYM's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — CHYM and CXM both carry a full feed there.
The central trade-off
CHYM (Chime Financial, Inc. Class A Common Stock): the stronger current systematic profile, led by momentum and quality.
CXM (Sprinklr, Inc.): the counter-case, on value, risk resilience, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CHYMCHYM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CXMCXM on combined revenue and EPS growth.
Value
CXMCXM on the peer-relative Value factor, by 23 points.
Momentum
CHYMCHYM on the Momentum factor, by 12 points.
Lower downside
CXMCXM on Risk Resilience, by 10 points.
Analyst upside
CHYMCHYM on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CHYM | CXM | Note |
|---|---|---|---|
| Implied upside to target | +20.8% | +14% | CHYM has more room |
| Target dispersion | +46.9% | +6.5% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 24 | 9 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor CHYM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 67 vs 66 |
| Fundamentals | CHYMon balance | revenue growth 7.2% vs -2.6%; EPS growth 50.1% vs 73.6%; TTM ROE 2.8% vs 1.4%; gross margin 88.9% vs 65.6%; operating margin 1.8% vs 5.4% — CHYM takes 3 of 5 decided legs, not all of them |
| Valuation | CXM | Value 40 vs 63 |
| Technicals | CHYM | Price vs 50-day 12.1% vs 14.9%; vs 200-day 39.6% vs 16.5% |
| Risk Resilience | CXM | Risk Resilience 52 vs 62 |
| Analyst expectations | CHYM | Target upside 20.8% vs 14% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CHYM and CXM and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CHYM.
How the comparison changed
120 daily snapshots · May 27 – Nov 13CHYM lead: Stable — the AIQ differential has held near 1 points over 30 sessions.
- Today
- CHYM +1
- 67 vs 66
- 7 sessions ago
- CXM +1
- 65 vs 66
- 30 sessions ago
- CHYM +3
- 63 vs 60
- 90 sessions ago
- CXM +5
- 61 vs 66
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
7 bullish / 2 bearish / 2 neutral, conflicted
Only CHYM
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.01%)
- Accumulation Pattern — bullish, volume, medium horizon (1.56x)
- Keltner Channel Breakout — bullish, volatility, short horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Overbought — bearish, momentum, short horizon
- Stochastic Overbought Rollover — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
3 bullish / 1 bearish, conflicted
Only CXM
- Low Volume Rally Warning — bearish, volume, short horizon (0.62x)
Both carry 3 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Uptrend Structure Active.
CHYM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +1.57%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +2.26%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CXM closes the Momentum gap — currently 12 points behind, the largest single contributor to CHYM's edge.
- 2CXM's Low Volume Rally Warning resolves — a bearish volume rule currently active against it.
- 3CHYM's conflicting signal state resolves bearish — it currently carries 7 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CHYM leads on balance| Metric | CHYM | CXM |
|---|---|---|
| Revenue growth (YoY) | 7.2% | -2.6% |
| EPS growth (YoY) | 50.1% | 73.6% |
| Gross margin | 88.9% | 65.6% |
| Operating margin | 1.8% | 5.4% |
| Return on equity (TTM) | 2.8% | 1.4% |
| Debt to equity | 0.07 | 0.08 |
Performance
CHYM leads 5 of 6 windows| Metric | CHYM | CXM |
|---|---|---|
| 1 week (5 sessions) | 7.1% | 1.9% |
| 1 month (20 sessions) | 13.1% | 16.6% |
| 3 months (63 sessions) | 6.7% | 1.5% |
| 6 months (126 sessions) | 89.7% | 33.1% |
| Year to date | 33.3% | -12.6% |
| 1 year (252 sessions) | 66.1% | -9.3% |
Technicals
CHYM has the stronger structure| Metric | CHYM | CXM |
|---|---|---|
| RSI (14) | 70.5 | 62.8 |
| ADX (14) | 21.6 | 32.3 |
| Price vs 50-day | 12.1% | 14.9% |
| Price vs 200-day | 39.6% | 16.5% |
| Volatility (1M, annualized) | 37% | 36.8% |
Risk
CXM is the more resilient| Metric | CHYM | CXM |
|---|---|---|
| Beta | 1.74 | 0.14 |
| Sharpe ratio | 1.16 | -0.03 |
| Sortino ratio | 1.8 | -0.04 |
| Max drawdown | -41.1% | -41.3% |
| Current drawdown | -2.9% | -17.2% |
| Annualized volatility | 60.7% | 44.3% |
| Value at risk (95%) | -5.6% | -4.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CHYM or CXM?
On the Algovestiq AIQ Score, CHYM is the stronger of the two as of Nov 15, 2026, scoring 67 against CXM's 66. The edge comes from momentum and quality. CXM is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CHYM or CXM the better buy right now?
CHYM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor CHYM over CXM?
The composite weights Quality, Value, Momentum and Risk Resilience. CXM leads Value by 23 points; CHYM leads Momentum by 12 points; CHYM leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CHYM or CXM?
Analyst price targets imply +20.8% upside for CHYM and +14% for CXM, so the Street currently favors CHYM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CHYM or CXM?
CXM is the better-valued of the two on the peer-relative Value factor. CXM on the peer-relative Value factor, by 23 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CHYM or CXM?
CXM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CHYM or CXM?
CHYM on the Momentum factor, by 12 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CHYM or CXM?
CXM is the more resilient of the two, so the other name carries the higher downside risk. CXM on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CHYM more profitable than CXM?
The profitability evidence is mixed: gross margin 88.9% vs 65.6%; operating margin 1.8% vs 5.4%; ttm roe 2.8% vs 1.4%. CHYM leads on two measures and CXM on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is CHYM's lead over CXM getting stronger or weaker?
CHYM lead: Stable — the AIQ differential has held near 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the CHYM vs CXM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CXM closes the Momentum gap — currently 12 points behind, the largest single contributor to CHYM's edge; CXM's Low Volume Rally Warning resolves — a bearish volume rule currently active against it; CHYM's conflicting signal state resolves bearish — it currently carries 7 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about CHYM and CXM?
CHYM: 7 bullish / 2 bearish / 2 neutral, conflicted. CXM: 3 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CHYM is Golden Cross Active (bullish, long horizon). On CXM it is Golden Cross Active (bullish, long horizon).
Compare CHYM and CXM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.